Crossmark

Severe pneumonia with formation of a pulmonary cavity associated with long-term rituximab therapy in multiple sclerosis

Published Online: 2020-10-12

Published Print: 2020-12

Authors

Schwake, Carolin

Gold, Ralf https://orcid.org/0000-0002-7223-3052
License Information

Text and Data Mining valid from 2020-10-12

Version of Record valid from 2020-10-12
More Information

Article History

Received: 12 May 2020

Accepted: 19 June 2020

First Online: 12 October 2020

Consent for publication

: Consent has been obtained.

: CS has nothing to report.RG received speaker’s and board honoraria from Baxter, Bayer Schering, Biogen Idec, CLB Behring, Genzyme, Merck Serono, Novartis, Stendhal, Talecris, and Teva. His department received grant support from Bayer Schering, Biogen Idec, Genzyme, Merck Serono, Novartis, and Teva. All not related to the content of this manuscript.

Document is current